MTOR and Behcet disease: While a study demonstrated that mutant forms of HDAC5 (HDAC5AA) activate the mTOR pathway and promote the survival and regeneration of retinal ganglion cells (RGCs)52, it is important to note that BD can significantly affect patients' eyes, establishing a connection between BD and vascular-related diseases.